JAVIER MOLINA-DURAN: Open Payments
NPI 1447865027 · MODESTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 31 payments from 14 companies in 2025. Trend: 2023 $923 · 2024 $1,283 · 2025 $816
Food & beverage: $737Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $324 |
| ABBVIE INC. | 5 | $128 |
| Incyte Corporation | 3 | $67 |
| LEO Pharma Inc. | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 1 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| GENZYME CORPORATION | 1 | $36 |
| UCB, Inc. | 1 | $29 |
| PFIZER INC. | 1 | $28 |
| Lilly USA, LLC | 1 | $27 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, OPZELURA, Bimzelx, CIBINQO, TALTZ, ADBRY.
Industry payments across CA — which companies pay providers there.
